- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-17-0004119
_PRIVATE_LIMITED_383653.webp)
About Cyamopsis Biotech (India) Private Limited
Data last updated:
Cyamopsis Biotech (India) Private Limited is a private limited company based in Sirsa, Haryana, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 14 March 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U01136HR2012PTC045395. Its GSTIN is 06AAECD1986H1ZK (Haryana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹7.3 Cr and a paid-up capital of ₹7.26 Cr. It was formerly known as Dada Ganpati Guar Products Private Limited. It is led by directors including Anju Jalan and Suresh Kumar Singla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 12th Km Stone Hisar Road Village – Moriwala, Sirsa, Haryana, India – 125060.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.18 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹29.81 Lakh (net margin 0.8%) and EBITDA of ₹1.82 Cr (EBITDA margin 4.9%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 3% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹17.28 Cr and satisfied charges of ₹13.27 Cr on record. The company has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹6.67 Cr; the latest was in June 2016. The company has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 23 overdue payments to 1 micro and small supplier.
Cyamopsis Biotech (India) Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-17-0004119). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cyamopsisbiotech.com.
Company details
Recognitions & Rankings of Cyamopsis Biotech (India)
Contact details
Cyamopsis Biotech (India) Private Limited's registered office is in Sirsa, Haryana. Its website is cyamopsisbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address12th Km Stone Hisar Road Village – Moriwala, Sirsa, Haryana, India – 125060
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Cyamopsis Biotech (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cyamopsis Biotech (India) is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cyamopsis Biotech (India) Private Limited, buy the company report.
Financials of Cyamopsis Biotech (India) Private Limited
FY 2025 filings availableCyamopsis Biotech (India) Private Limited reported revenue of ₹37.18 Cr (up 4% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 4% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.82 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹29.81 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cyamopsis Biotech (India) Private Limited, buy the company report.
Board of directors of Cyamopsis Biotech (India) Private Limited
Cyamopsis Biotech (India) has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anju Jalan Also directs: Cos Ra Laboratories Private Limited | Director | 14 Mar 2012 | 14 Years 8 Months | Current |
| Suresh Kumar Singla | Director | 14 Mar 2012 | 14 Years 8 Months | Current |
| Raj Kumar Jalan | Director | 14 Mar 2012 | 14 Years 8 Months | Current |
| Pankaj Khemka Also directs: Ohm Entertainment Private Limited | Director | 14 Mar 2012 | 14 Years 8 Months | Current |
Auditor
Cyamopsis Biotech (India) Private Limited is audited by S. L. Goyal & Co. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S. L. Goyal & Co. | FY 2022 | 001903N |
Shareholding
The shareholding of Cyamopsis Biotech (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cyamopsis Biotech (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jul 2024 | 100961112 | Others | ₹15.3 Cr | Open | |
| 16 May 2024 | 100921536 | Axis Bank Limited | ₹1.68 Cr | Open | |
| 05 Apr 2024 | 100917906 | Axis Bank Limited | ₹10 Lakh | Open | |
| 26 Sep 2023 | 100794100 | Hdfc Bank Limited | ₹19.81 Lakh | Open | |
| 29 Nov 2012 | 10395326 | State Bank of India | ₹13.27 Cr | Satisfied |
To see the full charge records of Cyamopsis Biotech (India) Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Cyamopsis Biotech (India) Private Limited has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹6.67 Cr; the latest was in June 2016.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2016 | Rights issue | ₹2.4 Cr | Investors: Ohm Entertainment Private Limited , 3 individuals |
| Nov 2012 | Funding round | ₹2.91 Cr | Investors: Blooms Texent Private Limited , 3 individuals |
| Jul 2012 | Funding round | ₹3.75 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Cyamopsis Biotech (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Cyamopsis Biotech (India) Private Limited was last rated by Brickwork on 24 May 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Brickwork | 24 May 2021 |
To see the full credit ratings and regulatory alerts of Cyamopsis Biotech (India) Private Limited, buy the company report.
MSME payment delays
Cyamopsis Biotech (India) Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 23 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| M/S Dada Ganpati Engineers |
To see the full MSME payment records of Cyamopsis Biotech (India) Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Cyamopsis Biotech (India) has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAECD1986H1ZK | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cyamopsis Biotech (India) Private Limited, buy the company report.
Recent activity
Cyamopsis Biotech (India) Private Limited has 4 board changes on record since 2012: 4 appointments. The latest: Anju Jalan was appointed as Director on 14 Mar 2012.
3 earlier events are in the company report.
Frequently asked questions
Cyamopsis Biotech (India) is an active private limited company based in Sirsa, Haryana, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 14 March 2012 (14+ years old) and is registered under CIN U01136HR2012PTC045395.
Cyamopsis Biotech (India) has 4 current directors:
- Anju Jalan - Director
- Suresh Kumar Singla - Director
- Raj Kumar Jalan - Director
- Pankaj Khemka - Director
The latest financial statements of Cyamopsis Biotech (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cyamopsis Biotech (India) is 06AAECD1986H1ZK, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Cyamopsis Biotech (India) is U01136HR2012PTC045395. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cyamopsis Biotech (India) was incorporated on 14 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Cyamopsis Biotech (India) has 3 deals on record (2 funding rounds, 1 rights issue), with disclosed funding of ₹6.67 Cr; the latest was in June 2016.
Anju Jalan was appointed as Director on 14 Mar 2012. Pankaj Khemka was appointed as Director on 14 Mar 2012. Raj Kumar Jalan was appointed as Director on 14 Mar 2012. Cyamopsis Biotech (India) has 4 board changes on record in total.
Yes, Cyamopsis Biotech (India) is registered as a small enterprise under Udyam registration (number: UDYAM-HR-17-0004119).
Cyamopsis Biotech (India) has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 23 overdue payments to 1 micro and small supplier. The latest return was filed on 08 Jun 2019.
Cyamopsis Biotech (India) can be reached through the website cyamopsisbiotech.com. Its registered office is in Sirsa, Haryana, India.

